In the days of the Armada, a fleet of warships, the scuttlebutt was the rumor or gossip that would spread throughout the ship. Today, Armada Law Corp presents The Scuttlebutt, a daily summery of news articles that people within the cannabis, hemp and plant medicine industries are chatting about along with links to the full articles.
In today’s news:
#californiacannabis – “Humboldt Cannabis reform initiative — which received over 7,000 petition signatures and will be on the March 2024 ballot — would eliminate mixed-light and indoor farming, limit the number of permits the county can issue, cap farm size to 10,000 square feet and only allow one cultivation permit to be issued per person or corporation. Humboldt County Planning and Building Director John Ford told the supervisors that the initiative, if approved by voters, would destroy the viability of legal cannabis farming in the county.
“We could see farms shutting down just because they can’t comply with the regulatory requirements that have been put in place,” Ford said.”
#psilocybin – “Far from the hippie culture of the 1960s that embraced psilocybin and other psychedelics as a way to “turn on, tune in, drop out,” recent studies into the drug’s efficacy have focused on its use in helping reduce the symptoms of post-traumatic stress disorder, anxiety and depression found in combat veterans and survivors of abuse.
House Bill 2107 was advanced by the Oklahoma House of Representatives on Thursday and can now be heard in the Senate. Its author, state Rep. Daniel Pae, R-Lawton, said Texas already has adopted similar legislation, and it’s also being considered in Montana, Missouri, Pennsylvania and Arizona.”
#cbdproducts – “House Speaker Clay Schexnayder, who wrote hemp legislation in 2022, took up the issue with the Louisiana health department, and, according to the Illuminator, he accused the department of “misinterpreting his legislation.”
Health department officials “have acknowledged the agency mistakenly approved about 230 products it shouldn’t have, specifically vape cartridges that some manufacturers disguised as CBD tinctures,” the Illuminator reported.
Schexnayder said nearly 400 unlawful products had been approved.
Some of the confusion around what the Louisiana law permits relates to how many “servings” of THC are permitted in hemp-derived products.”
#californiacannabis – “A messy case of legal fingerpointing between two California companies has apparently ended amicably, with both Unrivaled Brands and People’s California agreeing to a settlement, according to a press release.
Although the terms of the settlement were not immediately disclosed, the end result is that both companies will “request a stay of all pending litigation,” according to the release.
The two companies became involved in a legal brawl last year, suing each other over various allegations of breach of contract, fraud, and other supposed misdeeds.”
#cannabis – “Tens of thousands of commercial truckers are leaving their jobs, resulting in higher prices and barren shelves. What’s motivating this mass exodus? Look no further than the federal government’s outdated policies toward marijuana.
Despite the reality that state governments have legalized cannabis use under certain circumstances for the majority of Americans, the federal government still classifies it in the same legal category (Schedule I) as heroin. As a result, commercially licensed truckers are strictly forbidden from consuming cannabis products during their off hours — even if they reside in a state where such use is legal.”
#cannabislaw – “A would-be cannabis business owner is bringing his constitutional challenge to Washington state’s residency requirement for cannabis operators to the Ninth Circuit.
In a notice filed Tuesday, Todd Brinkmeyer said he would appeal a February order issued by U.S. District Judge Benjamin H. Settle, which ended his lawsuit against the Washington State Liquor and Cannabis Board and found that the dormant commerce clause of the U.S. Constitution could not apply to cannabis because of its federal illegality.
The federal district court’s decision was at odds with a First Circuit ruling from August, which determined that the constitutional doctrine, which bars states’ ability to restrict interstate commerce, applied to Maine’s medical cannabis program and that regulators could not bar out-of-state investors from participating in the market.”
#cannabislaw – “In a complaint filed Thursday in Virgin Islands federal court, Ariel Petersen claimed that cannabis’ current classification under the CSA violates the Administrative Procedure Act in three ways, and asked the court to find that the DEA’s criteria and decisions were invalid and block the attorney general from keeping cannabis as a Schedule I substance.
According to the complaint, Congress has authorized the attorney general to remove any drug or substance from the schedules if those substances do not meet the requirements for inclusion, and requires the attorney general to update and republish its classifications on a biannual basis.
Petersen’s suit, however, alleges that these updates are subject to the notice-and-comment requirements of the APA, and that the government has not followed those procedures in its decision to keep cannabis on the CSA Schedule I list.”